Search research articles
Contact Us
Filters
Showing results (201-210 of 288) with videos related to
Page
of 29
Sort By:
Disease Markers
|
February 28, 2019
Prostatic Acid Phosphatase (PAP) Predicts Prostate Cancer Progress in a Population-Based Study: The Renewal of PAP?
Huan Xu, Fubo Wang, Huizhen Li, et al.
Future Science OA
|
November 13, 2018
Profiling and bioinformatics analyses of differential circular RNA expression in prostate cancer cells
Chunlei Zhang, Jun Xiong, Qi Yang, et al.
Cell Death & Disease
|
February 12, 2020
Retraction Note: Sirt3 suppresses calcium oxalate-induced renal tubular epithelial cell injury via modification of FoxO3a-mediated autophagy
Yonghan Peng, Cheng Yang, Xiaolei Shi, et al.
Scientific Reports
|
February 12, 2016
Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer
Jia Li, Shancheng Ren, Hai-Long Piao, et al.
Molecular & Cellular Proteomics : MCP
|
November 8, 2015
Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer
Shancheng Ren, Yaping Shao, Xinjie Zhao, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
March 17, 2012
Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer
Shancheng Ren, Chuanliang Xu, Zilian Cui, et al.
Journal of Endourology
|
January 11, 2019
Endoscopic Balloon Dilatation in the Treatment of Benign Ureteral Strictures: A Meta-Analysis and Systematic Review
Chaoyue Lu, Wei Zhang, Yonghan Peng, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
July 26, 2018
The Natural Compound Myricetin Effectively Represses the Malignant Progression of Prostate Cancer by Inhibiting PIM1 and Disrupting the PIM1/CXCR4 Interaction
Chen Ye, Chao Zhang, Hai Huang, et al.
Journal of X-Ray Science and Technology
|
September 6, 2013
Imaging diagnosis and endoscopic treatment for ureteral fibroepithelial polyp prolapsing into the bladder
Chuanliang Xu, Zhensheng Zhang, Huamao Ye, et al.
International Immunopharmacology
|
February 29, 2024
Fragility index analysis for randomized controlled trials of approved biologicals and small molecule drugs in inflammatory bowel diseases
Xiaoyin Bai, Ziqi Wan, Yi Li, et al.
Page
of 29
Search research articles
Search
Showing results (201-210 of 288) with videos related to
Sort By:
Page
of 29
Disease Markers
|
February 28, 2019
Prostatic Acid Phosphatase (PAP) Predicts Prostate Cancer Progress in a Population-Based Study: The Renewal of PAP?
Huan Xu, Fubo Wang, Huizhen Li, et al.
Future Science OA
|
November 13, 2018
Profiling and bioinformatics analyses of differential circular RNA expression in prostate cancer cells
Chunlei Zhang, Jun Xiong, Qi Yang, et al.
Cell Death & Disease
|
February 12, 2020
Retraction Note: Sirt3 suppresses calcium oxalate-induced renal tubular epithelial cell injury via modification of FoxO3a-mediated autophagy
Yonghan Peng, Cheng Yang, Xiaolei Shi, et al.
Scientific Reports
|
February 12, 2016
Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer
Jia Li, Shancheng Ren, Hai-Long Piao, et al.
Molecular & Cellular Proteomics : MCP
|
November 8, 2015
Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer
Shancheng Ren, Yaping Shao, Xinjie Zhao, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
March 17, 2012
Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer
Shancheng Ren, Chuanliang Xu, Zilian Cui, et al.
Journal of Endourology
|
January 11, 2019
Endoscopic Balloon Dilatation in the Treatment of Benign Ureteral Strictures: A Meta-Analysis and Systematic Review
Chaoyue Lu, Wei Zhang, Yonghan Peng, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
July 26, 2018
The Natural Compound Myricetin Effectively Represses the Malignant Progression of Prostate Cancer by Inhibiting PIM1 and Disrupting the PIM1/CXCR4 Interaction
Chen Ye, Chao Zhang, Hai Huang, et al.
Journal of X-Ray Science and Technology
|
September 6, 2013
Imaging diagnosis and endoscopic treatment for ureteral fibroepithelial polyp prolapsing into the bladder
Chuanliang Xu, Zhensheng Zhang, Huamao Ye, et al.
International Immunopharmacology
|
February 29, 2024
Fragility index analysis for randomized controlled trials of approved biologicals and small molecule drugs in inflammatory bowel diseases
Xiaoyin Bai, Ziqi Wan, Yi Li, et al.
Page
of 29